Cell And Gene Articles, App Notes, Case Studies, & White Papers
-
A Scalable Manufacturing Platform For The Purification Of Stem Cell Derived Exosomes
5/16/2025
EV production scale increases require paired robust, scalable, and cost-effective downstream processes. Process parameters can be tailored for therapeutic exosome programs and allow for maximum exosome recovery.
-
Navigating CGT Commercialization: Key Areas For Success
5/13/2024
The cutting-edge realm of cell and gene therapy holds immense promise for revolutionizing healthcare, and its successful commercialization hinges on several key factors.
-
Regulatory Considerations For Excipients Used In Lipid Nanoparticles
8/15/2024
Review the regulatory classification of LNPs, liposomes, and novel excipients as well as specific requirements outlined in regulatory guidance documents and strategies to navigate emerging challenges.
-
Enabling The Rapid, Reproducible Manufacturing Of TranspoCART Cells
2/21/2025
Learn how an innovative technology streamlines Transpocart cell production, making rapid and consistent manufacturing a reality for cell therapies.
-
The Complete Guide To Immunohistochemistry
9/24/2024
Immunohistochemistry (IHC) is a tool for visualizing the distribution and localization of antigens within tissue sections. Learn about IHC sample preparation, detection and amplification systems, and more.
-
Fast And Accurate Detection Of Alzheimer's Disease Targets
9/17/2024
In this study, the detection of three Alzheimer’s disease targets are highlighted: Human BDNF (Brain-derived neurotrophic factor), Tau, and TREM2 (Triggering receptor expressed on myeloid cells 2).
-
Creating A Sustainable Business Model For Cell And Gene Therapies
10/5/2023
Avoid product launch delays and expand patient access to CGTs by understanding and meeting regulatory guidelines and securing approval for reimbursement of treatment costs.
-
Linear Scale-Up Of hiPSC Cell Lines Using Vertical-Wheel Bioreactors
2/3/2025
Explore how innovative bioreactor technology enables consistent and efficient scale-up of human induced pluripotent stem cells (hiPSCs) from 100ml to 3L, ensuring optimal cell yield and quality.
-
Strategic Clinical Consulting Success Stories
2/13/2024
Explore real-world examples of how the combination of strategic consulting, regulatory insights, and technical expertise can impact the development and approval process.
-
Establishing Reproducible Polymer Nanoparticle (PNP) Manufacturing
12/10/2024
Explore how the HIT SCAN™ platform enhances polymer nanoparticle (PNP) gene therapies by addressing design, reproducibility, and scalability challenges.